ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 918,60
-0,24%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aptinyx Inc (APTX)

  7. Aptinyx Inc (APTX) Actualités

APTX

Aptinyx (APTX)

Aptinyx Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:APTX
DateHeureSourceTitreSymboleSociété
21/12/202316h52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTXAptinyx Inc
27/06/202320h14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
24/05/202322h50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
24/05/202322h44Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APTXAptinyx Inc
23/05/202314h26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APTXAptinyx Inc
15/05/202322h46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:APTXAptinyx Inc
11/05/202314h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
28/04/202322h19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APTXAptinyx Inc
30/03/202322h31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTXAptinyx Inc
30/03/202322h05Business WireAptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic AlternativesNASDAQ:APTXAptinyx Inc
27/02/202322h03Business WireAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateNASDAQ:APTXAptinyx Inc
31/01/202313h47Business WireAptinyx to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APTXAptinyx Inc
05/01/202322h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
12/12/202212h25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
10/11/202213h45Business WirePreclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for NeuroscienceNASDAQ:APTXAptinyx Inc
10/11/202205h26TipRanksSVB Securities Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
09/11/202216h16TipRanksBMO Capital Remains a Buy on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
08/11/202222h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTXAptinyx Inc
08/11/202222h05Business WireAptinyx Reports Third Quarter 2022 Financial Results and Recent HighlightsNASDAQ:APTXAptinyx Inc
03/11/202212h30Business WireClinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH GrantNASDAQ:APTXAptinyx Inc
18/10/202213h45Business WireAptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022NASDAQ:APTXAptinyx Inc
25/08/202213h30Business WireAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy BodiesNASDAQ:APTXAptinyx Inc
12/08/202213h15Business WireAptinyx Reports Results from Phase 2b Study of NYX-2925 in FibromyalgiaNASDAQ:APTXAptinyx Inc
05/08/202214h38TipRanksBMO Capital Sticks to Its Buy Rating for Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
04/08/202222h05Business WireAptinyx Reports Second Quarter 2022 Financial Results and Recent HighlightsNASDAQ:APTXAptinyx Inc
03/08/202204h35TipRanksSVB Securities Maintains a Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
15/07/202213h47Business WireAptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022NASDAQ:APTXAptinyx Inc
24/06/202220h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APTXAptinyx Inc
22/06/202213h47Business WireAptinyx to Participate in H.C. Wainwright 1st Annual Mental Health ConferenceNASDAQ:APTXAptinyx Inc
23/05/202212h29TipRanksH.C. Wainwright Thinks Aptinyx’s Stock is Going to RecoverNASDAQ:APTXAptinyx Inc
 Showing the most relevant articles for your search:NASDAQ:APTX

Dernières Valeurs Consultées

COIN
BITFEUR
BIT
UC7T5A
Unicredit Bank
HITB
MTCETH
Medical Token Currency
USOTC
INGXF
Innergex Renewable Energy (PK)
AMEX
SEPW
Allianzim US Large Cap B...
BIT
PB3362
BNP PARIBAS ISSUANCE
BIT
UC72PC
Unicredit Bank
BIT
UC4NHD
Unicredit Bank
TSXV
HEL
BIT
UC6Y70
Unicredit Bank
HUOB
EGAMEUSDT
EVERY GAME
NYSE
TXU
Txu
BIT
UC86DL
Unicredit Bank
TSXV
BRM
Biorem
NASDAQ
CIVC
Ctr Invts & Consult
UNSW3
IOTXETH
IoTeX Network
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés